This is the result that will likely attract the most attention, because it points toward a possible therapeutic overlap between metabolic intervention and cancer outcomes
Studies lasting up to 52 weeks with various GLP-1 medications show no systematic changes in calcitonin concentrations
International Urology and Nephrology
However, neither the innate nor the adaptive immune response is affected by the DPP-4 inhibitors being used clinically (128), and reassuringly, there is no evidence for any increased risk of infections in the pooled safety analyses (119123) or in the CV safety outcome trials (125127), in line with the view that the catalytic activity of DPP-4 is not necessary for the co-stimulatory role of CD26 in T-cell activation
Itching that persists past 24 hours is flagged as possible sensitivity, and severe itching with hives, warmth or spreading redness is listed as a reason to seek prompt guidance
So is GLP-1, copied to treat diabetes and obesity